TOPAZ1
Basic information
Region (hg38): 3:44241886-44332098
Previous symbols: [ "C3orf77" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TOPAZ1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 80 | 90 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 80 | 6 | 7 |
Variants in TOPAZ1
This is a list of pathogenic ClinVar variants found in the TOPAZ1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-44242082-C-G | not specified | Uncertain significance (Sep 16, 2021) | ||
3-44242133-C-T | not specified | Uncertain significance (Dec 07, 2023) | ||
3-44242151-C-T | not specified | Uncertain significance (Sep 22, 2023) | ||
3-44242172-C-T | not specified | Uncertain significance (Aug 27, 2024) | ||
3-44242174-G-A | not specified | Uncertain significance (Jan 23, 2023) | ||
3-44242177-G-T | not specified | Uncertain significance (Aug 27, 2024) | ||
3-44242222-A-C | not specified | Uncertain significance (Jul 27, 2021) | ||
3-44242237-G-A | not specified | Uncertain significance (Jan 12, 2024) | ||
3-44242285-G-A | not specified | Uncertain significance (Jul 13, 2021) | ||
3-44242333-T-TCGTCAGACC | Benign (Dec 31, 2019) | |||
3-44242337-C-T | not specified | Uncertain significance (Jun 07, 2023) | ||
3-44242376-T-G | not specified | Uncertain significance (Jun 16, 2023) | ||
3-44242381-T-G | not specified | Uncertain significance (Sep 26, 2023) | ||
3-44242388-C-T | not specified | Uncertain significance (Apr 27, 2022) | ||
3-44242855-A-G | not specified | Uncertain significance (Apr 27, 2024) | ||
3-44242860-A-C | not specified | Uncertain significance (Dec 30, 2023) | ||
3-44242993-A-C | not specified | Uncertain significance (Dec 27, 2023) | ||
3-44243104-G-A | not specified | Uncertain significance (Aug 12, 2021) | ||
3-44243143-A-G | not specified | Uncertain significance (Dec 19, 2023) | ||
3-44243152-C-A | not specified | Uncertain significance (Mar 01, 2024) | ||
3-44243202-C-G | not specified | Uncertain significance (Jan 17, 2024) | ||
3-44243255-G-A | not specified | Uncertain significance (Sep 24, 2024) | ||
3-44243272-G-A | not specified | Uncertain significance (Apr 10, 2023) | ||
3-44243299-C-T | not specified | Likely benign (Apr 07, 2022) | ||
3-44243363-A-G | not specified | Uncertain significance (Oct 06, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TOPAZ1 | protein_coding | protein_coding | ENST00000309765 | 20 | 90213 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.977 | 0.0225 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.90 | 600 | 746 | 0.804 | 0.0000377 | 11131 |
Missense in Polyphen | 104 | 196.74 | 0.52861 | 3395 | ||
Synonymous | 1.71 | 235 | 271 | 0.867 | 0.0000142 | 3097 |
Loss of Function | 6.06 | 12 | 64.5 | 0.186 | 0.00000366 | 1030 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Important for normal spermatogenesis and male fertility. Specifically required for progression to the post-meiotic stages of spermatocyte development. Seems to be necessary for normal expression levels of a number of testis-expressed gene transcripts, although its role in this process is unclear. {ECO:0000250|UniProtKB:E5FYH1}.;
Intolerance Scores
- loftool
- rvis_EVS
- 3.04
- rvis_percentile_EVS
- 99.23
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Topaz1
- Phenotype
- reproductive system phenotype; endocrine/exocrine gland phenotype; cellular phenotype;
Gene ontology
- Biological process
- apoptotic process;spermatid development;spermatocyte division;ncRNA transcription;positive regulation of meiotic cell cycle phase transition
- Cellular component
- cytosol
- Molecular function